News Archive

Items in English for the News Archive subsection of the News section.

Events 2007

"Rare Diseases - From Assesment of Needs to Seting Priorities", Zalău, Romania, 2-3 november 2007
| Program | Gallery |

1st HAE International Leadership Conference, Frankfurt am Main, 19-21 Octomber 2007
| Program | Gallery |

Events 2008

XXII International Complement Workshop, Basel, Switzerland, 28 September - 2 October 2008
| Program (link extern)|

Pharming Investigator Meeting, Amsterdam, Netherlands, June 2008

Annual Meeting of the Romanian Society of Allergology and Clinical Immunology, Bucharest October 16-18, 2009

Workshop: From gene to recombinant therapy in hereditary angioedema
 

Date: October 16

Time: 14.00-15.00

Venue: Hotel Hilton, Bucharest

Chairpersons: Anastasios Germenis, Greece; Dumitru Moldovan, Romania

XXI World Allergy Congress, Buenos Aires 6-10 december, 2009

The WAC is the most exciting international congress gathering allergists and other related specialties from all over the world. You’ll learn about new recommendations for diagnosis and treatment of allergic and immunologic diseases as well as new research findings and how they will influence your practice.
WAC 2009 will take place from Sunday, December 6 to Thursday, December 10, 2009 in Buenos Aires, Argentina. The main venue of the Congress is the Sheraton Buenos Aires Hotel & Convention Center. The Marriott Plaza Hotel will be the additional venue for some educational activities. The official language of the Congress is English. Simultaneous translation into Spanish will be provided in some sessions.

Novel small molecule bradykinin B2 receptor antagonists

Blockade of the bradykinin B(2) receptor provides therapeutic benefit in hereditary angioedema (HAE) and potentially in many other diseases. In a recent study published in the Journal of Medicinal Chemistry, Gibson and his coleagues from the  Department of Medicinal Chemistry, Jerini AG, Berlin, Germany, describe the development of highly potent B(2) receptor antagonists with a molecular weight of approximately 500 g/mol.
Source: PMID: 19552431  / J Med Chem. 2009 Jul 23;52(14):4370-9.
Last update: 08.25.2009

Hereditary angioedema with normal C1 inhibition

Until recently, it was assumed that hereditary angioedema was a disease resulting exclusively from a genetic deficiency of the C1 inhibitor. Acording to a study published this year in Current Allergy and Asthma Reports, one of the most respected experts in the field of hereditary angioedema, Prof. Konrad Bork from the Department of Dermatology, Johannes Gutenberg University, Mainz, Germany, described at the first time in 2000, families with hereditary angioedema, normal C1 inhibitor activity, and protein in plasma.